AzTrials
AzTrials

PainNCT05926921

Musical Intervention During IV-line Placement in Neonates

A study testing music in people with Pain, run by Spaarne Gasthuis at 1 site in Netherlands.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to test the effect of music in reducing the pain felt by newborn children during an intravenous line procedure. An intravenous line is a small tube brought into a vein by using a needle. The main questions it aims to answer are: 1. Read more about this study

Who is it for?
Any age
Conditions the study is for
Pain
What is being tested?
music
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteNetherlands
Study dates
19 Jun 2023to 9 Oct 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • connected to a monitor that records vital signs
  • receives an IV-line

Who cannot join

  • has hearing impairment

Trial locations and contacts

1 site in 1 country.

Andrieke Knottnerus contact

0232240000

aknottnerus@spaarnegasthuis.nl

Netherlands1 site, 1 recruiting
  • Spaarne Gasthuis Haarlem Zuid

    Haarlem, North Holland, 2035 RC

    Recruiting

Other trials in Netherlands

About this study

Official title: 'The Effect of Musical Intervention on the Indicators of Pain in Newborns Undergoing IV-line Placement'

The goal of this clinical trial is to test the effect of music in reducing the pain felt by newborn children during an intravenous line procedure. An intravenous line is a small tube brought into a vein by using a needle. The main questions it aims to answer are:

  1. Does playing a lullaby during intravenous line procedures affect the vital signs and behavior of a newborn, compared to not playing music?
  2. How do parents and medical staff experience the music that's being played? Participants will all receive the same care and treatments as usual. The only difference being about half of the participants will be randomly assigned to the group that gets music.

Researchers will compare the music group to the non-music group to see if there is any difference in vital signs and behaviors of the child.

Read the detailed description

After inclusion, a participant will be randomized by drawing a sealed, opaque envelope, the contents of which will be either group A: no music, or group B: music. The outcome assessor will then perform a baseline measurement of vital signs and Neonatal Infant Pain Score. Then, Brahms Lullaby will be played from a speaker. When the needle is first introduced into the skin, a second measurement will be performed. For every attempt needed to succesfully place the intravenous line, an additional measurement will be done. Finally, after succesful placement of the intravenous line is confirmed by NaCl flush, a final measurement will be done. Afterwards, a short questionnaire will be filled in by the parents and the medical staffmember(s) that performed the intravenous line.

The study groups will be compared to each other in outcome measures, and there will be statistical correction for demographic and clinical confounders, which will be collected from medical files. The research hypothesis is that group B will show a smaller increase in vital signs and NIPS on average during the procedure, compared to group A.

Conditions
Pain
Being tested
music
Keywords
intravenous line, newborn, music, pain management, musical therapy
Medical subject headings
Pain, Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • musicOther

    Brahms' Lullaby will be played from a speaker at 50 decibels

Study groups in NCT05926921
Study groupRoleWhat they receive
musicActive comparatorBrahms lullaby at 50-60dB (depending on distance to speaker), played during the intravenous line procedure.
Receives: Other: music
no musicNo interventionNo intervention, care as usual.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. HR

    heart rate

    Measured: one day

  2. RR / BR

    respiratory rate / breathing rate

    Measured: one day

  3. O2 Sat

    oxygen saturation

    Measured: one day

  4. NIPS

    neonatal infant pain scale

    Measured: one day

Secondary outcomes (2)
  1. parents' experience (questionnaire)

    four short questions regarding parents' thoughts about the intervention

    Measured: one day

  2. IV-line performers' experience (questionnaire)

    four short questions regarding staff' thoughts about the intervention

    Measured: one day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jul 2023
  2. Study start19 Jun 2023
  3. Primary completion9 Oct 2024 (estimated)
  4. Study completion9 Oct 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05926921
Sponsor's protocol ID
newwave
Status last verified
Jun 2024
First submitted
9 Jun 2023
Last updated
13 Jun 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing music in people with Pain, run by Spaarne Gasthuis at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Andrieke Knottnerus (0232240000, aknottnerus@spaarnegasthuis.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

HR (time frame: one day). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jun 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in